Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Lisiak

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Cancer Drug Targets|November 17, 2017
Autophagy as a Potential Therapeutic Target in Breast Cancer TreatmentNatalia Lisiak, Ewa Toton, Maria Rybczynska
Postepy Higieny I Medycyny Doswiadczalnej (Online)|July 4, 2014
[Autophagy, new perspectives in anticancer therapy]Natalia Lisiak, Ewa Totoń, Maria Rybczyńska
International Journal of Molecular Sciences|April 13, 2024
Human Vault RNAs: Exploring Their Potential Role in Cellular MetabolismMagdalena Taube, Natalia Lisiak, Ewa Totoń, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 24, 2016
The Synthetic Oleanane Triterpenoid HIMOXOL Induces Autophagy in Breast Cancer Cells via ERK1/2 MAPK Pathway and Beclin-1 Up-regulationNatalia Lisiak, Ewa Toton, Blazej Rubis, et al.
International Journal of Molecular Sciences|November 11, 2022
The Role of Telomerase in Breast Cancer's Response to TherapyEliza Judasz, Natalia Lisiak, Przemysław Kopczyński, et al.
Scientific Reports|September 26, 2025
Telomerase inhibitors TMPyP4 and BIBR 1532 show synergistic antitumor activity in combination with chemotherapeutic drugsAleksandra Romaniuk-Drapała, Ewa Totoń, Natalia Lisiak, et al.
Cancers|July 13, 2024
Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic StrategiesAleksandra Romaniuk-Drapała, Ewa Totoń, Magdalena Taube, et al.
Molecules (Basel, Switzerland)|November 9, 2024
Evaluation of Cytotoxic Activity of Cell Biomass from <i>Eryngium planum</i> and <i>Lychnis flos-cuculi</i> on Melanoma Cancer CellAnastasia Aliesa Hermosaningtyas, Ewa Totoń, Natalia Lisiak, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2024
Cytotoxic effects of kinetin riboside and its selected analogues on cancer cell linesEwa Totoń, Natalia Lisiak, Aleksandra Romaniuk-Drapała, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cellsMalgorzata Kucinska, Julia Pospieszna, Jing Tang, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Cancer Drug Targets|November 17, 2017
Autophagy as a Potential Therapeutic Target in Breast Cancer TreatmentNatalia Lisiak, Ewa Toton, Maria Rybczynska
Postepy Higieny I Medycyny Doswiadczalnej (Online)|July 4, 2014
[Autophagy, new perspectives in anticancer therapy]Natalia Lisiak, Ewa Totoń, Maria Rybczyńska
International Journal of Molecular Sciences|April 13, 2024
Human Vault RNAs: Exploring Their Potential Role in Cellular MetabolismMagdalena Taube, Natalia Lisiak, Ewa Totoń, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 24, 2016
The Synthetic Oleanane Triterpenoid HIMOXOL Induces Autophagy in Breast Cancer Cells via ERK1/2 MAPK Pathway and Beclin-1 Up-regulationNatalia Lisiak, Ewa Toton, Blazej Rubis, et al.
International Journal of Molecular Sciences|November 11, 2022
The Role of Telomerase in Breast Cancer's Response to TherapyEliza Judasz, Natalia Lisiak, Przemysław Kopczyński, et al.
Scientific Reports|September 26, 2025
Telomerase inhibitors TMPyP4 and BIBR 1532 show synergistic antitumor activity in combination with chemotherapeutic drugsAleksandra Romaniuk-Drapała, Ewa Totoń, Natalia Lisiak, et al.
Cancers|July 13, 2024
Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic StrategiesAleksandra Romaniuk-Drapała, Ewa Totoń, Magdalena Taube, et al.
Molecules (Basel, Switzerland)|November 9, 2024
Evaluation of Cytotoxic Activity of Cell Biomass from <i>Eryngium planum</i> and <i>Lychnis flos-cuculi</i> on Melanoma Cancer CellAnastasia Aliesa Hermosaningtyas, Ewa Totoń, Natalia Lisiak, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2024
Cytotoxic effects of kinetin riboside and its selected analogues on cancer cell linesEwa Totoń, Natalia Lisiak, Aleksandra Romaniuk-Drapała, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2024
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cellsMalgorzata Kucinska, Julia Pospieszna, Jing Tang, et al.
Pageof 3